Diabetes & Endocrinology
751 - 765 of
975 Results
Sort Results:
Other:
The Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive Study)
October 2005
Article:
Actos (pioglitazone) reduces the risk of heart attack, stroke, and death in some patients with type 2 diabetes
October 2005
Article:
two new pending drugs for diabetes, Pargluva (muraglitazar) and Exubera (inhaled insulin)
September 2005
Other:
Safety Alert: LifeScan, Inc. Announces Worldwide Correction Concerning Certain Blood Glucose Meters
July 2005